Regarding medical applications, it was suggested by Nogalska et al. [102] that the MSTN gene promoter might be activated by an increase in NF-κB levels caused by Sporadic-inclusion body myositis (s-IBM), a common disease that causes progressive muscle waste and weakness. This evidence concerns the gene NFKB1 and inclusion body myositis.